BOOSTRIX® is indicated for active booster immunization against tetanus, diphtheria, and pertussis
Manufacturer # 58160084211
Brand Boostrix®
Manufacturer Glaxo Smith Kline
Country of Origin Unknown
Application Tdap Booster Vaccine
Container Type Single-Dose Vial
Dosage Form Injection
Generic Drug Code 24618
Generic Drug Name Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed, Preservative Free
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 58160084211
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Strength 5 Lf - 2.5 Lf - 8 mcg / 0.5 mL
Supplier_ID 488095
Type Intramuscular
UNSPSC Code 51201631
User Indicated for People 10 Years of Age and Older
Volume 0.5 mL
